Royalty Report: Medical, Device, Surgical – Collection: 1850

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 15

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 15

Primary Industries

  • Medical
  • Device
  • Surgical
  • Delivery
  • Catheter
  • Cancer
  • Therapeutic
  • Pain
  • implants
  • cardiac
  • obesity

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1850

License Grant
The Company entered into an agreement for the license for Epidural catheters used to infuse drugs into the epidural space in the spinal column (vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system (vii) Intra-aortic balloon catheters (viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.
Field of Use
Fields of Application)
(v) Epidural catheters used to infuse drugs into the epidural space in the spinal column.
(vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system.
(vii) Intra-aortic balloon catheters.
(viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.

IPSCIO Record ID: 180208

License Grant
The company entered into an agreement providing the company with exclusive rights in the United States and certain other countries to develop Licensors proprietary intravascular infusion catheter to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of pulmonary arterial hypertension (PAH).
License Property
The proprietary intravascular infusion catheter is to be used with its SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of PAH.  The Implantable System for Remodulin will be exclusive to Remodulin so long as we purchase a minimum percentage of our annual requirement for implantable pump systems from Licensor.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 268269

License Grant
Licensor will manufacture and supply the Implantable System for Remodulin, and Licensee will manufacture and supply Remodulin for use in the system. Each party will perform certain additional activities to support the commercialization of the Implantable System for Remodulin.
License Property
The system incorporates a proprietary Licensor intravascular infusion catheter with Medtronic’s SynchroMed® II implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin) in order to deliver Remodulin for the treatment of pulmonary arterial hypertension (PAH). We believe this technology has the potential to reduce many of the patient burdens and other complications associated with the use of external pumps to administer prostacyclin analogues.
Field of Use
The Parties wish to collaborate on the commercialization in the United States of the delivery of Remodulin® (treprostinil) injection drug to patients with pulmonary arterial hypertension using Medtronic implantable pumps, catheters, and programmers, and related Medtronic accessories.

IPSCIO Record ID: 1370

License Grant
The Company acquired exclusive worldwide rights to the GliaSite® Radiation Therapy System.

Licensor is willing to grant Licensee rights to the Licensor IP in the Territory with a limited field of use of intracavity radiation therapy (brachytherapy) of the brain (“Exclusive Field of Use”).

License Property
the GliaSite® Radiation Therapy System, the only FDA-cleared balloon catheter device used in the treatment of brain cancer.

GliaSite® Radiation Therapy System (RTS) is for the treatment of brain cancer, i.e. primary and recurrent gliomas and metastic brain tumors.  Specifically, the intended use of GliaSite® RTS is the management of surgically resectable brain tumors where adjuvant radiation therapy of the post-resection tissue bed is indicated.

IPSCIO Record ID: 3990

License Grant
The Foundation owns the Licensable Technology as defined. The Optionee specializes in developing technology and bringing new technologies to market; and desires to investigate and conduct due diligence with respect to the commercial viability of the Licensable Technology prior to executing the License Agreement.
License Property
'Licensable Patents' shall refer to and mean US Patent Application # 60/797,433 entitled 'Intra-jugular Catheter' and any U.S. or foreign patent applications, reissues, extensions, renewals, reexaminations, certificates of invention, substitutions, divisions, continuations, and continuations-in-part thereof having the Principal Investigator as an inventor and having the same priority date as the parent applications. The Field shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.
Field of Use
'Field' shall mean clinical use as a catheter for insertion into the vascular system of a patient to direct fluid flow, sampling of fluids and oxygenation monitoring.

IPSCIO Record ID: 166205

License Grant
Licensor grants an exclusive worldwide license, with tile right to sub-license, under Licensors Product Intellectual Property to make, have made, sell, or have sold, and otherwise commercialize, market and distribute the Product throughout the world.
License Property
Licensor has developed a proprietary drug delivery system, including drug infusion pumps, ports, catheters, programming systems and accessories.  The Product is a preservative-free injectable formulation or formulations of clonidine and all current or future analogs, modifications and improvements of clonidine.

The SynchroMed system is the only externally programmable, implantable, drug infusion system available today. Using telemetry, the clinician can program its pump to deliver precise doses of medication at specific times to provide optimum therapy for each patient. It is widely used with morphine sulfate to block pain signals traveling to the brain and is also used to treat severe spasticity associated with multiple sclerosis, spinal cord injury, cerebral palsy, and traumatic brain injury. Clinical trials are expected to be initiated in 1998.

Field of Use
The Licensee will test the use of clonidine, delivered directly to the spinal fluid by the Medtronic SynchroMed(R) implantable drug infusion system, in the treatment of chronic intractable pain. Intractable pain is typically defined as constant, long-term pain that is not manageable without intervention. Clonidine delivered intrathecally (inside the sheath that surrounds the spinal cord) may be effective in patients with pain who no longer experience adequate relief with intrathecal morphine. These patients, if not already using a SynchroMed system, will require its implant to deliver intrathecal clonidine.

IPSCIO Record ID: 28439

License Grant
The Licensor, government organization, desires to transfer inventions to the private sector through commercialization Licenses to facilitate the commercial development of products and processes for public use and benefit.  The Licensor granted a nonexclusive License under the Licensed Patent Rights in the United States of America including its Territories, Commonwealths and Possessions to use and have used the Licensed Process to administer Drug to treat gliomas. Licensee does not have the right to subLicense.
License Property
U.S. Patent 5,720,720 Convection-Enhanced Drug Delivery including 1L13-PE38QQR, for treating gliomas delivered or recommended to be delivered using the Licensed Process.
Field of Use
Licensed Fields of Use Nonexclusive for using the Licensed Process to administer Drug to treat gliomas.

IPSCIO Record ID: 257711

License Grant
The Licensee has a License Agreement for the IP related to the its thoracostomy kit,  the  Thoraguide from the Inventors, two individuals.
License Property
The Thoracostomy kit involves the insertion of a thin plastic tube into the space between the lungs and the chest wall. The tube may be attached to a suction device to remove excess fluid or air.
Field of Use
A thoracostomy is a small incision of the chest wall, with maintenance of the opening for drainage. It is most commonly used for the treatment of a pneumothorax. This is performed by physicians, emergency response nurses, and paramedics, usually via needle thoracostomy, or with a thoracostomy tube (chest tube).

A pneumothorax is a collapsed lung. A pneumothorax occurs when air leaks into the space between your lung and chest wall. This air pushes on the outside of your lung and makes it collapse. Pneumothorax can be a complete lung collapse or a collapse of only a portion of the lung.

The Licensee develops new disposable medical devices.

IPSCIO Record ID: 27723

License Grant
The company granted to us exclusive, world-wide rights under intellectual property, including patents, trade secrets and know-how, to develop and commercialize products using the DUROS drug delivery technology in the fields of the delivery of drugs by catheter to the central nervous system to treat selected central nervous system disorders, the delivery of drugs by catheter to the middle and inner ear, the delivery of drugs by catheter into the pericardial sac of the heart, the delivery of selected drugs by catheter into vascular grafts and the delivery of selected cancer antigens.
License Property
The DUROS system is a miniature drug-dispensing pump made out of titanium which can be as small as a wooden matchstick.
Field of Use
This agreement pertains in the fields of the delivery of drugs by catheter.

IPSCIO Record ID: 114966

License Grant
A group of prominent spine surgeons agree to assist in the development of the Synergy Spinal System for royalty payments of any sales generated.
License Property
Synergy Spinal System is in the spinal implant product category and is used in spine fusion procedures.  The Synergy Spinal System consists of rods, hooks and screws that are attached to vertebrae adjacent to an injured or defective area of the spine. Our system is a 'universal' implant system that allows surgeonsto treat both the thoracic and lumbar portions of the spine.  The Synergy Spinal System does not require that surgeons follow a single surgical protocol, but provides several options, and can be used in both anterior and posterior applications, in both adults and children.  The Synergy Spinal System was designed to minimize the height and bulk of its implants, reducing the risk of irritation, inflammation and infection for the patient. It is consistently ranked as having one of the lowest profiles of commonly available spinal implant systems.
Field of Use
This agreement pertains to the medical device industry–spinal implants and orthobiologics.

IPSCIO Record ID: 163887

License Grant
Assignor sells, assigns, conveys, transfers and delivers to Assignee, its successors and permitted assigns, the Spot Catheter Patents and the Spot Catheter Technology and the Linear Catheter Patents and the Linear Catheter Technology to be used only in the Field of Use.
License Property
Assignor is in the business of developing implantable cardiac defibrillators and electrophysiology catheters. The IP includes patents and U.S. Patent Applications, Serial Nos. 08/496,947 and 09/073,651 and corresponding foreign patents.
Field of Use
The Field of Use shall mean the radio frequency (RF) cardiac ablation therapy field.  This agreement pertains to the medical industry.

IPSCIO Record ID: 237382

License Grant
Assignor, a stockholder, assigned its interest in the products and patents.
License Property
US10513583 – Balloon system and methods for treating obesity
Field of Use
The Assignee is an early-stage medical device company that has developed and is commercializing a unique non-surgical product for the treatment of obesity.

IPSCIO Record ID: 203456

License Grant
Attached to this settlement agreement, the Licensor grants a worldwide non-exclusive license under Licensors Patent Rights and Know-how to make, have made for it, use, and sell Licensed Products. The license granted herein is expressly limited to the specific Licensed Products defined herein, and does not include the right to sublicense except to an Affiliate.

This license granted for Laser Angioplasty Catheters is non-cancelable by Licensee during the period from the Effective Date through June 30, 2009.

This license granted for Non-Laser Functioning Catheters and Guidewires for use with Licensees Laser Therapy Systems is non-exclusive.

License Property
The licensors patents include, but are not limited to, Method of Improving the Biocompatibility of Solid Surfaces, Surface Coating Agents and Substrate Surface Preparation.

The Licensed Products means Medical Products that are surface-treated with photoreactive polyvinylpyrrolidone copolymer, non-photoreactive polyvinylpyrrolidone, photoreactive polyacrylamide copolymer, one or more of the photoreactive crosslinking agents known to the parties as PR01 and PR04, a compound for promoting polymer-to-metal adhesion known to the parties as TL03, or any combination of these compounds, for the purpose of providing a lubricious surface to the Medical Products.

MEDICAL PRODUCTS-B1 Laser Angioplasty Catheters
The Medical Products means excimer laser angioplasty catheters specifically adapted for coronary and peripheral use. Medical Products includes Licensees chronic total occlusion laser angioplasty catheters.

MEDICAL PRODUCTS-B2 Non-Laser Functioning Catheters and Guidewires for use with Spectranetics Laser Therapy Systems
The Medical Products means the following Licensee-labeled non-laser functioning catheters and guidewires for Licensees laser therapy system that are specifically designed and labeled for use solely with laser angioplasty catheters (I) BIAS sheath, (ii) support catheters, (iii) cardiac lead locking device, and (iv) chronic total occlusion steerwires.  Medical Products does not include catheters for (I) infusion of diagnostic, therapeutic, or embolic agents in the neurovascular region, or (ii) insertion of therapeutic embolic devices in the neurovascular region. Medical Products does not include catheters used to deliver stents of any type.

Field of Use
Licensee designs, manufactures, markets and distributes single-use medical devices used in minimally invasive surgical procedures within the vascular system in conjunction with our proprietary excimer laser system.

IPSCIO Record ID: 1099

License Grant
Licensor, an individual, hereby assigns to Licensee his entire right, title and interest in and to all patents and copyrights, trade secrets, know-how, and other intellectual property rights which relate to the Field and which exist now or at any time prior to the expiration of the term of the Consulting Agreement.
License Property
'Products' shall mean valved tip angiographic and infusion catheters that incorporate U.S. Patent #5,085,635.
Field of Use
'Field of Interest' and 'Field' shall mean products and methods related to the concept embodied in the Products of a valved tip to allow injection or infusion of fluids in the body.

IPSCIO Record ID: 202863

License Grant
The parties desire to cancel the Prior Supply Agreement and amend the Prior Development & License Agreement and replace the royalty section.
License Property
Licensor is the owner of certain patent rights and know-how related to safety needles, and in particular, to developments described in U.S. Patents.

Licenor  shall use its best efforts to develop intravenous catheter Safety Needle Assemblies ('SNAs').

Field of Use
The term 'Field' shall mean short peripheral intravenous catheters, (three inches or less in length) including sideport peripheral catheters. Items intended to be sold as blood collection needles, syringe needles, winged infusion needles (butterflies), midline catheters, central and radial arterial catheters, and Peripherally Inserted Central Catheter (PICC) introducers are excluded from the Field.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.